Literature DB >> 22546022

Nonprogrammable and programmable cerebrospinal fluid shunt valves: a 5-year study.

Timothy J Hatlen1, David B Shurtleff, John D Loeser, Jeffrey G Ojemann, Anthony M Avellino, Richard G Ellenbogen.   

Abstract

OBJECT: Programmable valves (PVs) for shunting CSF have increasingly replaced nonprogrammable valves (NPVs). There have been only a few longer-term studies (≥ 5 years) conducted that have compared the effectiveness of NPVs with that of PVs for children with hydrocephalus, and only 1 study has reported NPVs as being favorable over PVs. The objective of this retrospective study was to compare the long-term survival of these 2 types of shunt valves.
METHODS: The authors collected data for all patients who underwent CSF shunt insertion or revision between January 1, 2000, and December 31, 2008. Patients underwent follow-up for a minimum of 2 years postoperatively. Statistical analyses were done using chi-square, Kaplan-Meier survival curve, and multivariate analyses.
RESULTS: A total of 616 valves were implanted, of which 313 were PVs and 303 were NPVs. Of these, 253 were original shunt implantations and 363 were revisions. The proportion of 5-year survival for NPVs (45.8%) was significantly higher than that for PVs (19.8%) (p = 0.0005, log-rank). The NPVs that survived longer than 6 months also survived through the 5th year better than the PVs (p = 0.0001).
CONCLUSIONS: The authors' data suggest that NPVs survive longer than PVs in children, but there is a need for prospective, case-control studies to confirm these data.

Entities:  

Mesh:

Year:  2012        PMID: 22546022     DOI: 10.3171/2012.1.PEDS10482

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  7 in total

Review 1.  Cerebrospinal Fluid Shunting Complications in Children.

Authors:  Brian W Hanak; Robert H Bonow; Carolyn A Harris; Samuel R Browd
Journal:  Pediatr Neurosurg       Date:  2017-03-02       Impact factor: 1.162

2.  Surgical outcome of the shunt: 15-year experience in a single institution.

Authors:  Sara Iglesias; Bienvenido Ros; Álvaro Martín; Antonio Carrasco; Miguel Segura; Andrea Delgado; Francisca Rius; Miguel Ángel Arráez
Journal:  Childs Nerv Syst       Date:  2016-08-05       Impact factor: 1.475

3.  Shunt survival rates by using the adjustable differential pressure valve combined with a gravitational unit (proGAV) in pediatric neurosurgery.

Authors:  Ulrich-W Thomale; Anna F Gebert; Hannes Haberl; Matthias Schulz
Journal:  Childs Nerv Syst       Date:  2012-11-08       Impact factor: 1.475

4.  Shunt technology for infants and a lifetime.

Authors:  Víctor J Fernández Cornejo; Samer K Elbabaa
Journal:  Childs Nerv Syst       Date:  2021-07-08       Impact factor: 1.475

5.  Exclusive use of fixed pressure valves for cerebrospinal fluid diversion in a modern adult cohort.

Authors:  Michael M McDowell; Michael C Chiang; Nitin Agarwal; Robert M Friedlander; Daniel A Wecht
Journal:  Heliyon       Date:  2018-12-29

6.  In vitro testing of explanted shunt valves in hydrocephalic patients with suspected valve malfunction.

Authors:  Christoph Bettag; Christian von der Brelie; Florian Baptist Freimann; Ulrich-Wilhelm Thomale; Veit Rohde; Ingo Fiss
Journal:  Neurosurg Rev       Date:  2021-05-24       Impact factor: 2.800

7.  MRI Compatibility: Automatic Brain Shunt Valve Recognition using Feature Engineering and Deep Convolutional Neural Networks.

Authors:  Luca Giancardo; Octavio Arevalo; Andrea Tenreiro; Roy Riascos; Eliana Bonfante
Journal:  Sci Rep       Date:  2018-10-30       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.